Value Lens: How the Carlyle deal prices SeQuent over its overseas peers
Advertisement

Value Lens: How the Carlyle deal prices SeQuent over its overseas peers

By Ankit Agarwal

  • 14 May 2020
Premium
Value Lens: How the Carlyle deal prices SeQuent over its overseas peers
Credit: 123RF.com

The Carlyle Group’s deal to take control of SeQuent Scientific Ltd appears to have come at a premium for the private equity...

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News